Sio Capital Management, LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Sio Capital Management, LLC disclosed 51 US equity positions worth $355.4m in its Q4 2024 13F filing. The largest position was ICLR at 11.5% of the reported book, followed by MMS and CI. Against the Q3 2024 filing, it opened 21 new positions, added to 9 and reduced 5 among the top 50 holdings.
What did Sio Capital Management, LLC own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | ICLR ICON PLC | Healthcare | 11.5% | $41.0m | 195,500 | – | new |
| 2 | MMS MAXIMUS INC | Industrials | 8.0% | $28.5m | 381,423 | 146% | added |
| 3 | CI THE CIGNA GROUP | Healthcare | 7.6% | $27.1m | 98,003 | 270% | added |
| 4 | LH LABCORP HOLDINGS INC | Healthcare | 7.3% | $26.0m | 113,293 | -35% | reduced |
| 5 | SNY SANOFI | 5.3% | $18.7m | 387,000 | – | new | |
| 6 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 5.2% | $18.5m | 174,811 | 37% | added |
| 7 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 4.6% | $16.3m | 451,793 | – | new |
| 8 | AVR ANTERIS TECHNOLOGIES GLOBAL | 3.7% | $13.2m | 2,370,000 | – | new | |
| 9 | ANNX ANNEXON INC | Healthcare | 3.4% | $12.1m | 2,367,007 | 65% | added |
| 10 | TFX TELEFLEX INCORPORATED | Healthcare | 3.3% | $11.9m | 66,772 | 70% | added |
| 11 | VTRS VIATRIS INC | Healthcare | 2.6% | $9.1m | 730,000 | – | new |
| 12 | OGN ORGANON & CO | Healthcare | 2.5% | $9.0m | 606,410 | – | new |
| 13 | VTYXUSD VENTYX BIOSCIENCES INC | 2.5% | $8.9m | 4,046,797 | 105% | added | |
| 14 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 2.5% | $8.8m | 160,051 | – | new |
| 15 | EMBC EMBECTA CORP | Healthcare | 2.5% | $8.8m | 425,574 | – | new |
| 16 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 2.2% | $7.7m | 1,054,651 | – | new |
| 17 | VXRT VAXART INC | 2.1% | $7.6m | 11,515,315 | -15% | reduced | |
| 18 | TARA PROTARA THERAPEUTICS INC | 2.1% | $7.6m | 1,437,500 | – | new | |
| 19 | CRGX CARGO THERAPEUTICS INC | 1.9% | $6.8m | 473,292 | 172% | added | |
| 20 | NMRA NEUMORA THERAPEUTICS INC. | Healthcare | 1.9% | $6.7m | 636,300 | – | new |
| 21 | SEPN SEPTERNA INC | 1.8% | $6.2m | 271,687 | – | new | |
| 22 | PROQR THERAPEUTICS N V | 1.5% | $5.4m | 2,054,593 | – | new | |
| 23 | PMVP PMV PHARMACEUTICALS INC | 1.5% | $5.4m | 3,572,167 | 11% | added | |
| 24 | IRON DISC MEDICINE INC | Healthcare | 1.3% | $4.7m | 73,511 | -61% | reduced |
| 25 | CATBUSD ASTRIA THERAPEUTICS INC | 1.3% | $4.5m | 504,887 | 0% | held | |
| 26 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 1.1% | $4.0m | 907,783 | – | new |
| 27 | AORT ARTIVION INC | Healthcare | 1.0% | $3.5m | 121,178 | 0% | held |
| 28 | ERAS ERASCA INC | Healthcare | 1.0% | $3.4m | 1,356,186 | -39% | reduced |
| 29 | TYRA TYRA BIOSCIENCES INC | Healthcare | 0.9% | $3.3m | 240,870 | -40% | reduced |
| 30 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 0.9% | $3.2m | 123,000 | 0% | held |
| 31 | ALPHA COGNITION INC | 0.7% | $2.6m | 434,700 | – | new | |
| 32 | QTTB Q32 BIO INC | 0.7% | $2.4m | 697,413 | – | new | |
| 33 | TELA TELA BIO INC | 0.5% | $1.9m | 630,000 | – | new | |
| 34 | NUVB NUVATION BIO INC | Healthcare | 0.5% | $1.8m | 668,115 | 0% | held |
| 35 | CNTX CONTEXT THERAPEUTICS INC | 0.4% | $1.4m | 1,328,352 | 0% | held | |
| 36 | ALEC ALECTOR INC | Healthcare | 0.3% | $1.2m | 615,628 | – | new |
| 37 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.3% | $1.0m | 177,004 | 0% | held |
| 38 | OVID OVID THERAPEUTICS INC | Healthcare | 0.3% | $933.7k | 1,000,000 | – | new |
| 39 | APRE APREA THERAPEUTICS INC | 0.3% | $910.0k | 276,603 | 0% | held | |
| 40 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 0.2% | $574.3k | 121,672 | 0% | held |
| 41 | CCCC C4 THERAPEUTICS INC | Healthcare | 0.2% | $558.0k | 155,000 | – | new |
| 42 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.1% | $530.9k | 71,458 | 0% | held |
| 43 | BOLD BOUNDLESS BIO INC | 0.1% | $470.0k | 162,058 | 0% | held | |
| 44 | NYXOAH S A | 0.1% | $406.7k | 50,839 | 0% | held | |
| 45 | MODULAR MED INC | 0.1% | $345.2k | 251,990 | 109% | added | |
| 46 | MESO MESOBLAST LTD | 0.1% | $229.7k | 11,600 | – | new | |
| 47 | NXTC NEXTCURE INC | 0.0% | $100.2k | 130,000 | 0% | held | |
| 48 | HUMACYTE INC | 0.0% | $91.7k | 49,998 | 0% | held | |
| 49 | 430 TERNS PHARMACEUTICALS INC | 0.0% | $55.4k | 10,000 | 0% | held | |
| 50 | ROCKET PHARMACEUTICALS INC | 0.0% | $15.4k | 400,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.